Physician profile

April J Johnson

Family · Oklahoma City, OK

NPI 1154758530

$5,851.77

in general payments reported to CMS, 2019-2025

19 companies · $65.11 in 2025

The $65.11 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).

See the full distribution for Family

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$480.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novartis Pharmaceuticals Corporation $3,407.84 2021-2022
Janssen Biotech, INC. $1,204.28 2022-2023 Tremfya, Simponi Aria
Abbvie INC. $179.50 2022-2025
Amgen INC. $152.14 2021-2025 Krystexxa
Astrazeneca Pharmaceuticals LP $150.19 2022-2023 Saphnelo
Ucb, INC. $117.59 2022
Janssen Scientific Affairs, LLC $99.68 2022
Edwards Lifesciences Corporation $94.52 2021-2023
Lilly USA, LLC $93.71 2022-2023 Taltz, Olumiant
Eli Lilly and Company $77.80 2023 Taltz
Glaxosmithkline, LLC. $57.27 2022
E.R. Squibb & Sons, L.L.C. $48.83 2021-2022
Abiomed $48.74 2024 Impella
Atricure, INC. $38.74 2021
Radius Health, INC. $18.31 2024 Tymlos
Show all 19 companies
CompanyGeneral paymentsYearsTop products
Surmodics, INC. $17.09 2023 Sublime Radial Access Guide Sheath, Sublime Radial Access 018 Rx Pta Dilatation Catheter, Sublime 014 Rx Pta Balloon Dilatation Catheter
Exact Sciences Corporation $16.09 2024 Cologuard Collection Kit
Myriad Women'S Health, INC. $14.82 2023 Myrisk
Pfizer INC. $14.63 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

April J Johnson

$5,851.77

in general payments reported 2019-2025

Years
2021-2025
Top company
Novartis Pharmaceuticals Corporation
Context
The $65.11 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).

https://glasscript.com/doctor/11124173/april-j-johnson

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.